Jérémie Meyer, Author at BaseLaunch

Features

KPMG’s R&D 2030 report is out now

Our partner KPMG’s latest report on R&D 2030 sheds light on the expected evolution in the R&D ecosystem. It highlights how the ecosystem is due…

Jérémie Meyer15.02.2019

Interviews

We are a small company with a big portfolio

“We are a small company with a big portfolio” After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s…

Jérémie Meyer22.01.2019

Features

BaseLaunch funds four healthcare ventures

BaseLaunch supports carefully selected ventures in two phases. After a very intense pressure test period, four projects were selected for Phase II of our second…

Jérémie Meyer22.01.2019

Features

Applications for 2019 are now open

We are excited to be open for new applications. We are looking for people and projects with breakthrough healthcare innovations mainly in the field of…

Jérémie Meyer22.01.2019

Features

Looking for an experienced drug developer to join an emerging biotech

A company we are supporting is currently finalizing a substantial Series A round with leading European investors. To complement the team, they are currently looking…

Jérémie Meyer22.01.2019

Features

Interviews

“We help to translate research into product, which benefits patients or society at large”

Herbert Reutimann, the CEO of Unitectra, the joint technology transfer organization of the Universities of Basel, Bern and Zurich, talks about the ways in which…

Jérémie Meyer11.12.2018

Jérémie Meyer

KPMG’s R&D 2030 report is out now

We are a small company with a big portfolio

BaseLaunch funds four healthcare ventures

Applications for 2019 are now open

Looking for an experienced drug developer to join an emerging biotech

Versant partners gear up for a $700M bonanza of biotech bets, with a special focus all their own

A Harvard Professor Made $400 Million in Moderna’s Biotech IPO

Black Diamond turns down an open stretch of R&D highway, headed to a showdown with oncogenes

Infographic: The Basel Biotech & Pharma Ecosystem

“We help to translate research into product, which benefits patients or society at large”

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us